Luciferase Reporter Cell Line - KLN205

The KLN205 cell line is a murine squamous cell carcinoma model originally derived from lung tissue. Due to its reproducible growth characteristics and responsiveness to therapeutic interventions, this cell line has been widely used in preclinical cancer research. KLN205 cells exhibit typical malignant epithelial cell characteristics, including rapid proliferation, invasiveness, and the ability to form solid tumors in syngeneic mouse models. These characteristics make the KLN205 cell line particularly valuable for studying tumor biology, metastasis, and immune system interactions. Researchers have utilized this cell line in various fields, from evaluating novel chemotherapeutic agents to exploring cancer immunotherapy.

The luciferase reporter gene cell line – KLN205 is a powerful tool constructed by stably integrating the luciferase gene into the KLN205 genome. This modification allows researchers to non-invasively and quantitatively monitor tumor dynamics in living organisms using bioluminescence imaging. Upon addition of the luciferase substrate, these cells emit photons that can be detected by highly sensitive cameras, enabling researchers to track tumor burden, metastatic spread, and treatment response in real-time without sacrificing animals. This reporter gene cell line has revolutionized cancer drug development by facilitating high-throughput screening of therapeutic candidates and enabling long-term assessment of treatment efficacy. Its high sensitivity allows for the detection of micrometastases and the quantification of minimal residual disease.